177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT05204927 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05204927
Sponsor: Curium US LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastasis From Malignant Tumor of Prostate

Start date: 2022-02-14
Primary completion: 2024-08-02
Enrollment: 439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.